Login / Signup

Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis.

Luca RicheldiMartin KolbStéphane JouneauWim A WuytsBirgit SchinzelSusanne StowasserManuel QuaresmaGanesh Raghu
Published in: BMC pulmonary medicine (2020)
INPULSIS (NCT01335464 and NCT01335477); INSTAGE (NCT02802345).
Keyphrases
  • idiopathic pulmonary fibrosis
  • interstitial lung disease
  • systemic sclerosis